Autoimmunity as a consequence of retrovirus-mediated expression of C- FLIP in lymphocytes

Immunity

Volumn 11, Issue 6, 1999, Pages 763-770

  Van Parijs, Luk ^a   Refaeli, Yosef ^b   Abbas, Abul K ^b   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; M PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CELL SELECTION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SPLEEN; T LYMPHOCYTE; THYMOCYTE; THYMUS;

EID: 0033426959     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80150-8     Document Type: Article

References (42)

1. Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N., and Nagata, S. (1995). Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11, 294-300.
2. Amakawa, R., Hakem, A., Kundig, T.M., Matsuyama, T., Simard, J.J., Timms, E., Wakeham, A., Mittruecker, H.W., Griesser, H., Takimoto, H., et al. (1996). Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84, 551-562.
3. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
4. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novelMORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815.
5. Brunner, T., Mogil, R.J., LaFace, D., Yoo, N.J., Mahboubi, A., Echeverri, F., Martin, S.J., Force, W.R., Lynch, D.H., Ware, C.F., et al. (1995). Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444.
6. Chervonsky, A.V., Wang, Y., Wong, F.S., Visintin, I., Flavell, R.A., Janeway, C.A., Jr., and Matis, L.A. (1997). The role of Fas in autoimmune diabetes. Cell 89, 17-24.
7. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
8. Cohen, P.L., and Eisenberg, R.A. (1991). Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269.
9. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., and Baltimore, D. (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401.
10. Dhein, J., Walczak, H., Baumler, C., Debatin, K.M., and Krammer, P.H. (1995). Autocrine T-cell suicide mediated by APO-1/Fas. Nature 373, 438-441.
11. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., and Puck, J.M. (1995). Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
12. Fukuyama, H., Adachi, M., Suematsu, S., Miwa, K., Suda, T., Yoshida, N., and Nagata, S. (1998). Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice. J. Immunol. 160, 3805-3811.
13. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195.
14. Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K., Iwahashi, H., Moriwaki, M., Nakajima, H., Miyagawa, J., Namba, M., et al. (1997). Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186, 613-618.
15. Ju, S.T., Panka, D.J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D.H., Stanger, B.Z., and Marshak-Rothstein, A. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
16. Kabra, N.H., Cado, D., and Winoto, A. (1999). A tailless fas-FADD death-effector domain chimera is sufficient to execute Fas function in T cells but not B cells of MRL-lpr/lpr mice. J. Immunol. 162, 2766-2774.
17. Kappler, J.W., Roehm, N., and Marrack, P. (1987). T cell tolerance by clonal elimination in the thymus. Cell 49, 273-280.
18. Kataoka, T., Schroter, M., Hahne, M., Schneider, P., Irmler, M., Thome, M., Froelich, C.J., and Tschopp, J. (1998). FLIP prevents apoptosis induced by death receptors but not byperforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J. Immunol. 161, 3936-3942.
19. Khoruts, A., Mondino, A., Pape, K.A., Reiner, S.L., and Jenkins, M.K. (1998). A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187, 225-236.
20. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
21. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
22. Nagata, S., and Suda, T. (1995). Fas and Fas ligand: Lpr and gld mutations. Immunol. Today 16, 39-43.
23. Newton, K., Harris, A.W., Bath, M.L., Smith, K.G.C., and Strasser, A. (1998). A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706-718.
24. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
25. Rathmell, J.C., Cooke, M.P., Ho, W.Y., Grein, J., Townsend, S.E., Davis, M.M., and Goodnow, C.C. (1995). CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376, 181-184.
26. Refaeli, Y., Van Parijs, L., London, C.A., Tschopp, J., and Abbas, A.K. (1998). Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615-623.
27. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A., Debatin, K.M., Fischer, A., and de Villartay, J.P. (1995). Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
28. Roman, C.A., Cherry, S.R., and Baltimore, D. (1997). Complementation of V(D)J recombination deficiency in RAG-1(-/-) B cells reveals a requirement for novel elements in the N terminus of RAG-1. Immunity 7, 13-24.
29. Rothstein, T.L., Wang, J.K., Panka, D.J., Foote, L.C., Wang, Z., Stanger, B., Cui, H., Ju, S.T., and Marshak-Rothstein, A. (1995). Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165.
30. Sabelko, K.A., Kelly, K.A., Nahm, M.H., Cross, A.H., and Russell, J.H. (1997). Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159, 3096-3099.
31. Sethna, M.P., van Parijs, L., Sharpe, A.H., Abbas, A.K., and Freeman, G.J. (1994). A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1, 415-421.
32. Shresta, S., Pham, C.T., Thomas, D.A., Graubert, T.A., and Ley, T.J. (1998). How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10, 581-587.
33. Smith, K.G., Strasser, A., and Vaux, D.L. (1996). CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176.
34. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J.L., Schroter, M., et al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521.
35. Tschopp, J., Thome, M., Hofmann, K., and Meinl, E. (1998). The fight of viruses against apoptosis. Curr. Opin. Genet. Dev. 8, 82-87.
36. Van Parijs, L., and Abbas, A.K. (1998). Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 280, 243-248.
37. Van Parijs, L., Refaeli, Y., Lord, J.D., Nelson, B.H., Abbas, A.K., and Baltimore, D. (1999). Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death (AICD). Immunity 11, 281-288.
38. Waldner, H., Sobel, R.A., Howard, E., and Kuchroo, V.K. (1997). Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159, 3100-3103.
39. Walsh, C.M., Wen, B.G., Chinnaiyan, A.M., O'Rourke, K., Dixit, V.M., and Hedrick, S.M. (1998). A role for FADD in T cell activation and development. Immunity 8, 439-449.
40. Wang, J., Lobito, A.A., Shen, F., Hornung, F., Winoto, A., and Lenardo, M.J. (2000). Regulation of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur. J. Immunol., in press.
41. White, J., Herman, A., Pullen, A.M., Kubo, R., Kappler, J.W., and Marrack, P. (1989). The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56, 27-35.
42. Zhang, J., Cado, D., Chen, A., Kabra, N.H., and Winoto, A. (1998). Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300.